Wells Fargo’s First Trust Nasdaq Pharmaceuticals ETF FTXH Stock Holding History
Bought
Maintained
Sold
Other funds holding FTXH
Wells Fargo's FTXH Position: Q3 2026 in Review
Wells Fargo increased its First Trust Nasdaq Pharmaceuticals ETF (FTXH) stake by 27,431,000% in Q3 2026, buying an estimated $11M and bringing the position to 274,311 shares worth $11.4M. The position accounts for ﹤0.01% of the portfolio, ranked #2003.
Wells Fargo first reported a position in FTXH in Q2 2019 and has held it in 27 quarters since. 71 funds tracked by Wall St. Rank hold FTXH as of Q3 2026.
- Wells Fargo held 274,311 shares of First Trust Nasdaq Pharmaceuticals ETF worth $11.4M as of Q3 2026.
- Wells Fargo bought 274,310 First Trust Nasdaq Pharmaceuticals ETF shares in Q3 2026, an estimated $11M.
- First Trust Nasdaq Pharmaceuticals ETF made up ﹤0.01% of Wells Fargo's portfolio in Q3 2026, its #2003 holding.
- Wells Fargo first reported a position in First Trust Nasdaq Pharmaceuticals ETF in Q2 2019 and has held it in 27 quarters since.
- 71 funds tracked by Wall St. Rank held First Trust Nasdaq Pharmaceuticals ETF as of Q3 2026.
Based on Wells Fargo's 13F filing for Q3 2026, filed 16 Nov 2026.